Inspections, Compliance, Enforcement, and Criminal Investigations

KIND, LLC - Close Out Letter 4/20/16

  

Department of Health and Human Services' logoDepartment of Health and Human Services

Public Health Service
 Food and Drug Administration
College Park, MD 20740

APR 20 2016


Daniel Lubetsky, CEO
Kind, LLC
1372 Broadway, 3rd Floor
New York, New York 10018
 

Re:437043
 

Dear Mr. Lubetsky:

The Food and Drug Administration has completed an evaluation of your firm's corrective actions in response to our Warning Letter issued March 17, 2015. Based on our evaluation, we conclude that you have satisfactorily addressed the violations contained in the Warning Letter. Future FDA inspections and regulatory activities will further assess the adequacy and sustainability of these corrections.

This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. The Agency expects you and your firm to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations be observed
during a subsequent inspection or through other means.


Sincerely,

/S/

Latasha A. Robinson
Branch Chief
Labeling and Dietary Supplement
        Compliance Branch
Division of Enforcement
Office of Compliance
Center for Food Safety
        and Applied Nutrition

Page Last Updated: 04/25/2016
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English